Literature DB >> 8053907

Biochemical properties of recombinant human beta-glucuronidase synthesized in baby hamster kidney cells.

M C Gehrmann1, M Opper, H H Sedlacek, K Bosslet, J Czech.   

Abstract

The cDNA sequence encoding human beta-glucuronidase [Oshima, Kyle, Miller, Hoffmann, Powell, Grubb, Sly, Troplak, Guise and Gravel (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 685-689] was expressed in baby hamster kidney (BHK) cells. After purification from the culture supernatant in one step by use of immunoaffinity chromatography, the biochemical properties of the enzyme were examined. With a pH optimum of 4.0, a Km of 1.3 mM and thermal stability up to 68 degrees C, this protein has characteristics very similar to those described for beta-glucuronidase from human placenta [Brot, Bell and Sly (1978) Biochemistry 17, 385-391. However, the recombinant product has several structural properties not previously reported for beta-glucuronidase isolated from natural sources. First, recombinant beta-glucuronidase is synthesized as a tetramer consisting of two disulphide-linked dimers. As can be inferred from the cDNA sequence, the enzyme possesses five cysteine residues after cleavage of the signal peptide. By introducing a C-terminal truncation, we eliminated the last cysteine at position 644. In the mutant, covalent linkage between two monomers is no longer observed, indicating that Cys-644 is involved in intermolecular disulphide-bond formation. The functional role of the disulphide bond remains elusive, as it was shown that (i) intracellular transport of the mutant is not impaired and (ii) it is still able to form an enzymically active tetramer. A second feature that has not previously been observed for beta-glucuronidase from any origin is the existence of two enzymically active species for recombinant beta-glucuronidase, when examined by gel filtration on a TSK 3000 column. With apparent molecular masses of 380 kDa and 190 kDa we propose that they represent tetramers and dimers respectively. Partial N-terminal sequencing and electrophoresis under denaturing conditions revealed that the dimers consist of subunits that have been proteolytically processed at their C-terminus losing 3-4 kDa in peptide mass. Controlled proteolysis demonstrates that the enzyme's overall protein backbone as well as its activity are resistant to a number of proteases. Only the C-terminal portion is susceptible to protease action, and the disulphide-linked form is readily converted into non-disulphide-bonded subunits. Pulse-chase analysis shows that human beta-glucuronidase remaining intracellular in BHK cells after synthesis undergoes a similar proteolytic processing event, i.e. a reduction in mass of 3-4 kDa.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053907      PMCID: PMC1137061          DOI: 10.1042/bj3010821

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Purification and characterization of rat liver microsomal beta-glucuronidase.

Authors:  J W Owens; P Stahl
Journal:  Biochim Biophys Acta       Date:  1976-07-08

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Purification and properties of beta-glucuronidase from human placenta.

Authors:  F E Brot; C E Bell; W S Sly
Journal:  Biochemistry       Date:  1978-02-07       Impact factor: 3.162

4.  Isolation and characterization of phosphorylated oligosaccharides from alpha-N-acetylglucosaminidase that are recognized by cell-surface receptors.

Authors:  K von Figura; U Klein
Journal:  Eur J Biochem       Date:  1979-03

5.  Purification and characterization of mouse kidney beta-glucuronidase.

Authors:  C W Lin; M L Orcutt; W H Fishman
Journal:  J Biol Chem       Date:  1975-06-25       Impact factor: 5.157

6.  Tumor-selective prodrug activation by fusion protein-mediated catalysis.

Authors:  K Bosslet; J Czech; D Hoffmann
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

7.  Isolation of rat transferrin using CNBr-activated sepharose 4B.

Authors:  H G Van Eijk; W L Van Noort
Journal:  J Clin Chem Clin Biochem       Date:  1976-10

8.  Properties of two molecular forms of beta-glucuronidase from the mollusc Littorina littorea L.

Authors:  T Diez; J A Cabezas
Journal:  Eur J Biochem       Date:  1979-01-15

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Purification and characterization of microsomal and lysosomal beta-glucuronidase from rat liver by use of immunoaffinity chromatography.

Authors:  Y Himeno Mnishimura; H Tsuji; K Kato
Journal:  Eur J Biochem       Date:  1976-11-15
View more
  6 in total

Review 1.  The role of beta-glucuronidase in drug disposition and drug targeting in humans.

Authors:  B Sperker; J T Backman; H K Kroemer
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

2.  An improved purification method for the lysosomal storage disease protein β-glucuronidase produced in CHO cells.

Authors:  Erica J Fratz-Berilla; Stephanie A Ketcham; Hamideh Parhiz; Muhammad Ashraf; Chikkathur N Madhavarao
Journal:  Protein Expr Purif       Date:  2017-07-19       Impact factor: 1.650

3.  Involvement of AP-2 binding sites in regulation of human beta-glucuronidase.

Authors:  Christiane Kunert-Keil; Bernhard Sperker; Sandra Bien; Gabriele Wolf; Markus Grube; Heyo K Kroemer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-10-28       Impact factor: 3.000

4.  Genetic engineering of IgG-glucuronidase fusion proteins.

Authors:  Ruben J Boado; William M Pardridge
Journal:  J Drug Target       Date:  2010-04       Impact factor: 5.121

5.  Verapamil regulates activity and mRNA-expression of human beta-glucuronidase in HepG2 cells.

Authors:  M Grube; C Kunert-Keil; B Sperker; H K Kroemer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-15       Impact factor: 3.000

6.  Native Electrophoresis-Coupled Activity Assays Reveal Catalytically-Active Protein Aggregates of Escherichia coli β-Glucuronidase.

Authors:  Gina G Burchett; Charles G Folsom; Kimberly T Lane
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.